Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Volvér is a venture capital firm that supports early-stage B2B technology-enabled companies. Founded to engage with founder teams at the pre-seed stage, the firm focuses on those with a deep understanding of their industry. Volvér has a portfolio of 7 companies and emphasizes a hands-on approach to problem-solving.
Volvér invests in early-stage B2B technology-enabled companies, typically as the first established investor. They focus on sectors such as SaaS, healthcare, biotech, energy, and consumer technology. The firm seeks coachable founder teams with a hustler and hacker mentality, emphasizing a hands-on approach to problem-solving.
Notable portfolio companies include QNTM Labs Aps, an advanced analytical laboratory for pharmaceutical companies; DanCann Pharma A/S, focused on cannabinoids; and MedicQuant, which offers rapid point-of-care tests for anticoagulants. Other companies include inBalance, Valyrion, Airtame Aps, and Knowledge Gate Group Aps.
Submit your pitch through their form at volver.vc.
Yes, Volvér typically engages as the first established investor in pre-seed rounds.
Specific details on follow-on investments are not provided, but their focus is primarily on pre-seed funding.
Information regarding the size of Volvér's current fund is not disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.